Antibodies as carriers of cytotosicity
Author(s)
Bibliographic Information
Antibodies as carriers of cytotosicity
(Contributions to oncology = Beiträge zur Onkologie, v. 43)
Karger, 1992
Available at 1 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Description and Table of Contents
Description
This review describes the knowledge to date in the use of antibodies and antibody-based derivatives for targeting effector molecules of cytotoxic drugs to selected cells in the body. Such target cells may be normal cells, cells infected with viruses, malignant cells or bacteria and parasites. Special emphasis is given to the antibody-dependent enzyme-mediated prodrug therapy (ADEPT), a recently developed biphasic antibody treatment modality. By critically reviewing the perspectives of monoclonal antibodies in therapy, this volume provides stimulating reading for oncologists, pharmacologists and researchers in internal medicine.
Table of Contents
- Vascular supply and endothelial reactions
- pharmacokinetics and pharmacodynamics of antibodies
- monophasic antibody treatment
- biphasic antibody treatment modalities.
by "Nielsen BookData"